Preclinical News and Research

RSS
AMRI announces fourth-quarter and full-year 2009 results

AMRI announces fourth-quarter and full-year 2009 results

HDC partners with New York surgery center to develop new molecular diagnostic tests for pancreatic cancer

HDC partners with New York surgery center to develop new molecular diagnostic tests for pancreatic cancer

Results validating performance of GSN’s proprietary Parental Support technology published

Results validating performance of GSN’s proprietary Parental Support technology published

Access Pharmaceuticals initiates Cobalamin technology program for targeted delivery of siRNA therapies

Access Pharmaceuticals initiates Cobalamin technology program for targeted delivery of siRNA therapies

Implanted ventricular assist heart pump for infants project awarded $5.6M federal contract

Implanted ventricular assist heart pump for infants project awarded $5.6M federal contract

Researchers evaluate ethical and legal issues of volunteers who participate in endoscopy-based studies

Researchers evaluate ethical and legal issues of volunteers who participate in endoscopy-based studies

NHLBI awarded four contracts to test new devices to help children with congenital heart defects

NHLBI awarded four contracts to test new devices to help children with congenital heart defects

Bioheart initiates REGEN Phase I Clinical Trial for testing genetically modified MyoCell in CHF patients

Bioheart initiates REGEN Phase I Clinical Trial for testing genetically modified MyoCell in CHF patients

Progenics Pharmaceuticals to present preclinical data of multiplex PI3K inhibitors

Progenics Pharmaceuticals to present preclinical data of multiplex PI3K inhibitors

Michael J. Fox Foundation announces more than $2.8M in awards to discover biomarkers of PD

Michael J. Fox Foundation announces more than $2.8M in awards to discover biomarkers of PD

Alkermes develops proprietary LinkeRx technology platform to create injectable antipsychotics

Alkermes develops proprietary LinkeRx technology platform to create injectable antipsychotics

BioCryst Pharmaceuticals announces fourth-quarter and full-year 2009 financial results

BioCryst Pharmaceuticals announces fourth-quarter and full-year 2009 financial results

1st Annual Biliary Tract-Gallbladder Cancer Research Symposium to be held at ASCO in Alexandria

1st Annual Biliary Tract-Gallbladder Cancer Research Symposium to be held at ASCO in Alexandria

PLX cell therapy may be an effective treatment for ischemic stroke disorder

PLX cell therapy may be an effective treatment for ischemic stroke disorder

ACT and Brown Cancer Center scientist collaborate in discovery of new therapeutics for cancer

ACT and Brown Cancer Center scientist collaborate in discovery of new therapeutics for cancer

HUCB-derived purified and expanded CD133+ cells may show promise in cellular cardiomyoplasty

HUCB-derived purified and expanded CD133+ cells may show promise in cellular cardiomyoplasty

Brentuximab vedotin-chemotherapy combination clinical trial for Hodgkin lymphoma announced

Brentuximab vedotin-chemotherapy combination clinical trial for Hodgkin lymphoma announced

Report: California biomedical industry faces unprecedented challenges

Report: California biomedical industry faces unprecedented challenges

Nanotope publishes preclinical data demonstrating cartilage regeneration

Nanotope publishes preclinical data demonstrating cartilage regeneration

Promising results from Soligenix' RiVax vaccine trials against ricin toxin

Promising results from Soligenix' RiVax vaccine trials against ricin toxin

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.